Concerning the affinity, we showed here that TBA can easily keep up with high-affinity antibodies such as the human epidermal growth factor receptor 2 (HER2)-binding cancer drug Trastuzumab (KD = 660 pM) [41]. The gene discussed is ERBB2; the disease is cancer.